Franciscan Missionaries of Our Lady Health System
Questions or Suggestions
Drug Information Questions
Search by name
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
Hazardous Drugs
Do Not Crush
REMS
Therapeutic Interchange
Do Not Tube-LALK
Do Not Tube-LACH
Restricted
CMS Self-Administered Drug Exclusion List
Look Alike Sound Alike Drugs
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
News
Boards
*COVID-19 Pharmacy Resources
Franciscan Missionaries of Our Lady Health System
Questions or Suggestions
Drug Information Questions
Search by name
Additional search options
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
Hazardous Drugs
Do Not Crush
REMS
Therapeutic Interchange
Do Not Tube-LALK
Do Not Tube-LACH
Restricted
CMS Self-Administered Drug Exclusion List
Look Alike Sound Alike Drugs
Webpage Links
Do Not Crush
Please review each of these drugs carefully.
acetaminophen
Controlled-release Tablet
albuterol
Extended-release Tablet
alendronate
Tablet - Note: Mucous membrane irritant
ALPRAZolam
Extended-release Tablet
amoxicillin
Extended-release Tablet
amoxicillin-clavulanate
Extended-release (b,h) Tablet
amphetamine-dextroamphetamine
Extended-release Capsule (a)
aspirin
Delayed-release Tablet
Enteric-coated Tablet
aspirin-dipyridamole
Extended-release Capsule
atomoxetine
Capsule - Note: capsule contents can cause ocular irritation
benzonatate
Capsule - Note: swallow whole; local anesthesia of the oral mucosa; choking could occur
bisacodyl
Enteric-coated (c) Tablet
Capsule - Liquid filled
brompheniramine-phenylephrine (non-formulary)
Extended-release (b) Capsule
budesonide
Extended-release Capsule
Enteric-coated (a) Capsule
Tablet - Note: coating on tablet is designed to break down at pH of 7.0 or above
buPROPion
Extended-release Tablet
Slow-release Tablet
carBAMazepine
Extended-release (a) Capsule
Extended-release (b) Tablet
carbidopa-levodopa
Extended-release (h) Tablet
carvedilol
Extended-release (a) Capsule - Note: may add contents of capsule to chilled, not warm, applesauce and consume immediately
cefaclor
Extended-release Tablet
cefuroxime
Tablet - Note: Taste (b) / use suspension for children
charcoal
Enteric-coated Tablet
chlorpheniramine
Extended-release (b) Tablet
cinacalcet
Tablet - Note: tablets are not scored and cutting may cause variable dosage accuracy
ciprofloxacin
Extended-release (b) Tablet
Extended-release Tablet
clarithromycin
Extended-release Tablet
cloNIDine
Extended-release Tablet
colestipol
Slow-release Tablet
cyclobenzaprine
Extended-release Capsule
cyclophosphamide
Tablet - Note: drug may be crushed but company recommends using injection
dabigatran
Capsule - Note: bioavailability increases by 75% when the pellets are taken without the capsule shell
darifenacin (non-formulary)
Slow-release Tablet
desvenlafaxine
Extended-release Tablet
dexmethylphenidate
Extended-release (a) Capsule
dextromethorphan-guaifenesin
Extended-release (h) Tablet
Extended-release Tablet
Slow-release Tablet
dextromethorphan/guaifenesin/phenylephrine
Slow-release (h) Tablet
diclofenac
Enteric-coated Tablet
Extended-release Tablet
Delayed-release Tablet
dilTIAZem
Tablet - Note: although not in the PI, the drug has a coating that is intended to release the drug over approximately 3 hours
Extended-release (a) Capsule
Extended-release Tablet
disopyramide
Extended-release Capsule Note: within a special capsule
divalproex sodium
Slow-release (b) Capsule - Note: mucous membrane irritant
Delayed-release Tablet
Extended-release Tablet
Extended-release (a) Capsule
docusate
Capsule - Note: Taste (e)
donepezil
Tablet - Note: crushing the 23 mg tablet may significantly increase the rate of absorption; the 5 and 10 mg tablet are not affected
doxazosin
Extended-release Tablet
doxycycline
Delayed-release Capsule
DULoxetine
Extended-release (a) Capsule - Note: may add contents of capsule to apple juice or applesauce but NOT chocolate
dutasteride (non-formulary)
Capsule - Note: drug may cause fetal abnormalities; women who are, or may become, pregnant, should not handle capsules; all women should use caution in handling capsules, especially leaking capsules
ergocalciferol
Liquid filled (d) Capsule
erythromycin
Enteric-coated (b) Tablet
Enteric-coated Tablet
Delayed-release Tablet
Enteric-coated Pellets (a) Capsule
esomeprazole
Delayed-release (a) Capsule
etravirine
Tablet - Note: tablet should be swallowed whole and not crushed; tablet may be dispersed in water
fenofibric acid
Extended-release Capsule
fentaNYL
Slow-release Lozenge - Note: this lollipop delivery system requires the patient to slowly dissolve in mouth
ferrous gluconate
Enteric-coated Tablet
ferrous sulfate
Enteric-coated (b) Tablet
Slow-release Tablet
fesoterodine (non-formulary)
Extended-release Tablet
fexofenadine-pseudoephedrine (non-formulary)
Extended-release Tablet
finasteride
Tablet - Note: women who are, or may become, pregnant, should not handle crushed or broken tablets
FLUoxetine
Enteric-Coated Tablet
fluvoxaMINE
Extended-release Capsule
gabapentin
Extended-release Tablet
galantamine
Extended-release Capsule
ganciclovir
Capsule - Note: Skin irritant
glipiZIDE
Extended-release Tablet
guaiFENesin
Extended-release (h) Tablet
Slow-release Tablet
guaifenesin-pseudoephedrine
Extended-release Capsule
Extended-release Tablet
guanFACINE
Extended-release Tablet
HYDROmorphone
Extended-release Tablet - Note: breaking, chewing, crushing, dissolving before swallowing or injecting could result in overdose
hydroxyurea
Capsule - Note: exposure to the powder may cause serious skin toxicities; healthcare workers should wear gloves to administer
hyoscyamine
Extended-release (h) Tablet
Extended-release Capsule
Controlled-release Tablet
ibandronate
Tablet - Note: chewed, crushed, or sucked tablets may cause oropharyngeal irritation
ibuprofen
Tablet - Note: taste (e)
imatinib
Tablet - Note: Taste (h) may be dissolved in water or apple juice
indomethacin
Extended-release (a,b) Capsule
isosorbide dinitrate
Sublingual form (g) Tablet
isosorbide mononitrate
Extended-release (h) Tablet
isradipine
Extended-release Tablet
lamoTRIgine
Extended-release Tablet
lansoprazole
Delayed-Release Capsule
Tablet - Note: orally disintegrating do not swallow; dissolve in water only and dispense via dosing syringe or NG tube
Slow-release Suspension - Note: contains enteric-coated granules; mix with water only; not for NG use
levETIRAcetam
Extended-release (b) Tablet
lithium
Extended-release Tablet
lopinavir-ritonavir
Film-coated (b) Tablet - Note: active ingredients are surrounded by a wax matrix to prevent healthcare exposure; women who are, or may become, pregnant, should not handle crushed or broken tablets
loratadine
Extended-release Tablet
loratadine-pseudoephedrine
Extended-release (b) Tablet
Extended-release Tablet
memantine
Extended-release (a) Capsule
mesalamine
Extended-release (a) Capsule - Note: maintain pH at less than or equal to 6.0
Slow-release (a) Tablet
Delayed-release Tablet
metFORMIN
Extended-release Tablet
methylphenidate
Extended-release Tablet
Extended-release (a) Capsule
metoprolol
Extended-release (h) Tablet
metroNIDAZOLE
Extended-release Tablet
minocycline
Extended-release Tablet
mirabegron (non-formulary)
Extended-release Tablet
morphine
Enteric-coated (a; not pudding) Capsule
Extended-release (a) Capsule - Note: may add contents of capsule to apple juice or applesauce but NOT chocolate
Extended-release (a) Capsule - Note: do not give via N/G tube
Extended-release (b) Tablet
mycophenolate mofetil
Capsule, Tablet - Note: Teratogenic potential (i)
Delayed-release Tablet
mycophenolic acid
Delayed-Release Tablet
naproxen
Delayed-release Tablet
Enteric-coated Tablet
Extended-release Tablet
nevirapine
Extended-release (b) Tablet
niacin
Slow-release (h) Capsule; Tablet
niCARdipine
Extended-release Capsule
nicotine
Lozenge - Note: integrity compromised by chewing or crushing
NIFEdipine
Extended-release Tablet
nitroglycerin
Sublingual route (g) Tablet
omega-3 polyunsaturated fatty acids
Capsule - Note: contents of capsule may erode walls of styrofoam or plastic materials
omeprazole
Delayed-release (a) Capsule
Delayed-Release Tablet
orphenadrine
Extended-release Tablet
oxybutynin
Extended-release Tablet
oxyCODONE
Extended-release Tablet - Note: tablet disruption may cause a potentially fatal overdose of oxyCODONE
oxyMORphone (non-formulary)
Extended-release Tablet
paliperidone
Extended-release Tablet
pancrelipase
Enteric-coated (a) Capsule
Extended-release (a) Capsule
Delayed-release (a) Capsule
pantoprazole
Slow-Release Tablet
PARoxetine
Extended-release Tablet
pentoxifylline
Extended-release Tablet
piroxicam
Capsule - Note: Mucous membrane irritant
posaconazole
Delayed-release Tablet - Note: company literature not available to show implications
potassium bicarbonate
Effervescent (f) Tablet
potassium chloride
Extended-release (b) Tablet
Extended-release (b,h) Tablet - Note: to make a liquid, place tablet in 120 mL of water; disperse for 2 minutes; stir
Extended-release (a,b) Capsule
potassium citrate
Wax-coated Tablet - prevents upper GI release
pramipexole
Extended-release Tablet
predniSONE
Delayed-Release Tablet - Note: release is dependent upon intact coating
propafenone
Extended-release Capsule
propranolol
Extended-release Capsule
pseudoephedrine
Extended-release (b) Tablet
pyridostigmine
Extended-release (b) Tablet
QUEtiapine
Extended-release Tablet
raloxifene
Tablet - Note: Taste; teratogenic potential (i)
ranolazine
Slow-Release Tablet
risedronate
Extended-release Tablet - Note: tablet coating is an important part of the delayed release
ritonavir
Tablet - Note: crushing tablets has resulted in decreased bioavailability of drug (b)
rivaroxaban
Tablet - Note: Crushed tablet must be given within 4 hours
rOPINIRole
Extended-release Tablet
sevelamer
Tablet - Note: tablets expand in liquid if broken or crushed (b)
sirolimus
Tablet - Note: pharmacokinetic NanoCrystal technology may be affected (b)
sulfaSALAzine
Delayed-release Tablet
tamsulosin
Slow-release Capsule
tapentadol (non-formulary)
Extended-release Tablet - Note: toxic dose may occur if tablet is split or crushed, causing rapid release and absorption of a potentially fatal dose
temozolomide
Capsule - Note: accidentally opened or damaged capsules require rigorous precautions to avoid inhalation or contact with the skin or mucous membranes (i)
theophylline
Extended-release Capsule - Note: contains beads that dissolve throughout the GI tract
Extended-release Tablet
Slow-release Tablet
tipranavir
Capsule - Note: oil emulsion within spheres; taste
tolterodine (non-formulary)
Extended-release Capsule
topiramate
Tablet/Capsule - Note: Taste (a)
traMADol
Extended-release Tablet - Note: tablet disruption may cause a potentially fatal overdose of drug
traZODone
Extended-release Tablet
valGANciclovir
Tablet - Note: Teratogenic and irritant potential (i,b)
valproic acid
Slow-Release Capsule
venlafaxine
Extended-release Capsule
verapamil
Extended-release (h) Tablet
Sustained-release (a) Capsule
Extended-release (a) Capsule
zolpidem
Extended-release Tablet
Sublingual form (g) Tablet